Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma

  • 0Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.

|

|

Summary

This summary is machine-generated.

Tumor-associated neutrophils (TANs) promote pancreatic cancer by secreting CCL5 and upregulating Nectin2. Targeting Nectin2 offers a new immunotherapy strategy for pancreatic ductal adenocarcinoma (PDAC).

Area Of Science

  • Immunology
  • Oncology
  • Cancer Research

Background

  • Tumor-associated neutrophils (TANs) are key players in pancreatic ductal adenocarcinoma (PDAC) progression.
  • Understanding TANs' pro-tumor mechanisms is crucial for developing effective PDAC immunotherapies.

Purpose Of The Study

  • To elucidate the pro-tumor mechanisms of TANs in PDAC.
  • To identify novel therapeutic targets for PDAC immunotherapy.

Main Methods

  • Utilized microarray, cytokine array, and single-cell transcriptomics.
  • Employed in vitro co-culture and in vivo models using human and mouse TANs.
  • Analyzed TAN interactions with cancer cells and T-cells.

Main Results

  • Increased TAN infiltration correlates with poor PDAC patient survival.
  • TANs secrete CCL5, promoting cancer cell migration and invasion.
  • TANs upregulate Nectin2, leading to CD8+ T-cell exhaustion; blocking Nectin2 improves T-cell function and suppresses tumor growth.

Conclusions

  • TANs drive PDAC progression via CCL5 secretion and Nectin2 upregulation.
  • Targeting the immune checkpoint Nectin2 presents a novel immunotherapy strategy for PDAC.